Brief: Neoliberal Psychedelics
Conspirituality
00:00
Concerns and Pitfalls of FDA Trials for Psychedelics
This chapter explores the concerns surrounding FDA trials for psychedelics like ketamine, psilocybin, and MDMA. The speakers discuss issues such as suicide incidents during ketamine trials, the rush to approve psilocybin and MDMA studies, doubts about the evidence and inflated cure rate claims in Australia, and the potential pitfalls of rolling out psychedelics without addressing underlying systemic issues.
Transcript
Play full episode
